Novartis (Leniolisib) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Novartis (Leniolisib) General Information

Description

A phase 3 rare disease drug intended for the treatment of activated PI3K delta syndrome.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Switzerland
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (Leniolisib) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (Leniolisib)‘s full profile, request access.

Request a free trial

Novartis (Leniolisib) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (Leniolisib)‘s full profile, request access.

Request a free trial

Novartis (Leniolisib) FAQs

  • Where is Novartis (Leniolisib) headquartered?

    Novartis (Leniolisib) is headquartered in Switzerland.

  • What industry is Novartis (Leniolisib) in?

    Novartis (Leniolisib)’s primary industry is Buildings and Property.

  • Is Novartis (Leniolisib) a private or public company?

    Novartis (Leniolisib) is a Private company.

  • What is the current valuation of Novartis (Leniolisib)?

    The current valuation of Novartis (Leniolisib) is .

  • What is Novartis (Leniolisib)’s current revenue?

    The current revenue for Novartis (Leniolisib) is .

  • Who are Novartis (Leniolisib)’s investors?

    Novartis has invested in Novartis (Leniolisib).

  • When was Novartis (Leniolisib) acquired?

    Novartis (Leniolisib) was acquired on 13-Aug-2019.

  • Who acquired Novartis (Leniolisib)?

    Novartis (Leniolisib) was acquired by Pharming Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process